Dynavax Technologies Tech Stack

Dynavax Technologies uses 8 technology products and services including jQuery CDN, Drupal, Microsoft Word, and more. Explore Dynavax Technologies's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Drupal
    Content Management System
  • Microsoft Word
    Editors
  • yepnope.js
    Javascript Frameworks
  • Amazon Web Services
    Platform As A Service
  • New Relic
    Real User Monitoring
  • Adobe Tag Manager
    Tag Management
  • ZURB Foundation
    UI Frameworks

Media & News

Dynavax Technologies's Email Address Formats

Dynavax Technologies uses at least 4 format(s):
Dynavax Technologies Email FormatsExamplePercentage
fmiddlelast@dynavax.comJMichaelDoe@dynavax.com
38%
firstl@dynavax.comJohnD@dynavax.com
25%
lfirst@dynavax.comDJohn@dynavax.com
25%
firlast@dynavax.comJohDoe@dynavax.com
12%

Frequently Asked Questions

Where is Dynavax Technologies's headquarters located?

Minus sign iconPlus sign icon
Dynavax Technologies's main headquarters is located at 2100 Powell St Suite 900 Emeryville, CA 94608 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Dynavax Technologies's phone number?

Minus sign iconPlus sign icon
You can contact Dynavax Technologies's main corporate office by phone at +1-510-848-5100. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dynavax Technologies's stock symbol?

Minus sign iconPlus sign icon
Dynavax Technologies is a publicly traded company; the company's stock symbol is DVAX.

What is Dynavax Technologies's official website and social media links?

Minus sign iconPlus sign icon
Dynavax Technologies's official website is dynavax.com and has social profiles on LinkedIn.

How much revenue does Dynavax Technologies generate?

Minus sign iconPlus sign icon
As of April 2024, Dynavax Technologies's annual revenue reached $75M.

What is Dynavax Technologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Dynavax Technologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dynavax Technologies have currently?

Minus sign iconPlus sign icon
As of April 2024, Dynavax Technologies has approximately 349 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. S.Chief Executive Officer And Director: E. G.Chief Human Resources Officer: J. C.. Explore Dynavax Technologies's employee directory with LeadIQ.

What industry does Dynavax Technologies belong to?

Minus sign iconPlus sign icon
Dynavax Technologies operates in the Biotechnology Research industry.

What technology does Dynavax Technologies use?

Minus sign iconPlus sign icon
Dynavax Technologies's tech stack includes jQuery CDNDrupalMicrosoft Wordyepnope.jsAmazon Web ServicesNew RelicAdobe Tag ManagerZURB Foundation.

What is Dynavax Technologies's email format?

Minus sign iconPlus sign icon
Dynavax Technologies's email format typically follows the pattern of fmiddlelast@dynavax.com. Find more Dynavax Technologies email formats with LeadIQ.

How much funding has Dynavax Technologies raised to date?

Minus sign iconPlus sign icon
As of April 2024, Dynavax Technologies has raised $200M in funding. The last funding round occurred on May 11, 2021.
Dynavax Technologies

Dynavax Technologies

Biotechnology ResearchCalifornia, United States201-500 Employees

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S. and the European Union for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older, and CpG 1018 adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant through global research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, seasonal influenza, universal influenza, plague, shingles and Tdap. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn.

Dynavax is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, martial and veteran status.

Section iconCompany Overview

Headquarters
2100 Powell St Suite 900 Emeryville, CA 94608 US
Phone number
+1-510-848-5100
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DVAX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $200M

    Dynavax Technologies has raised a total of $200M of funding over 18 rounds. Their latest funding round was raised on May 11, 2021.

  • $50M$100M

    Dynavax Technologies's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $200M

    Dynavax Technologies has raised a total of $200M of funding over 18 rounds. Their latest funding round was raised on May 11, 2021.

  • $50M$100M

    Dynavax Technologies's revenue is in the range of $50M$100M

© LeadIQ, Inc. All rights reserved.